The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The federal government has begun using artificial intelligence to review whether certain treatments are necessary for ...

Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...

On December 29, 2025, the Centers for Medicare & Medicaid Services (“CMS”) announced that it will distribute award amounts to all 50 states under ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Ten Medicaid systems vendors have agreed to provide low- or no-cost services to states over the next two years. The Trump ...

CMS announced the most recent round of awards Dec. 18, with hospitals receiving modest but targeted increases across primary care, behavioral health and other shortage specialties. The awards increase ...

The CMS has launched a pilot program that is based on an industry-standard application programming interface that gives providers access to patients’ claims data, according to a July 30 news release.

Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries with participating pharmaceutical manufacturers. Under ...

The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...